Replies to post #216071 on Biotech Values

[DewDiligence]

(Revised)—RVNC’s pro forma cash balance is $292.8M. This figure consists of: $134.8M of net currents assets on the 9/30/17 balance sheet (https://www.sec.gov/Archives/edgar/data/1479290/000147929017000042/rvncq31710q.htm#s566245125C215CE2A164C516887ADD48 ); and $158.0M net proceeds from the 12/5/17 public offering (https://finance.yahoo.com/news/revance-announces-closing-public-offering-210500723.html ), including exercise of the underwriter’s option and excluding the 6% underwriter’s fee.